Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73.
Recent gene expression profiling studies have identified five breast cancer subtypes, of which the basal-like subtype is the most aggressive. Basal-like breast cancer poses serious clinical challenges as there are currently no targeted therapies available to treat it. Although there is increasing ev...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
Springer Verlag
2011
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/24421/1/Rapamycin%20synergizes%20cisplatin%20sensitivity%20in%20basal.pdf |